We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
+15.79%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$48.8B
AUM Growth
+$4.38B
(+9.9%)
Cap. Flow
-$540M
Cap. Flow
% of AUM
-1.11%
Top 10 Holdings %
Top 10 Hldgs %
19.02%
Holding
2,611
New
251
Increased
862
Reduced
1,166
Closed
311
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$479M |
| 2 |
Costco
COST
|
+$402M |
| 3 |
Netflix
NFLX
|
+$355M |
| 4 |
Nike
NKE
|
+$321M |
| 5 |
Atlassian
TEAM
|
+$312M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$768M |
| 2 |
Cisco
CSCO
|
+$334M |
| 3 |
Amgen
AMGN
|
+$283M |
| 4 |
Fortinet
FTNT
|
+$267M |
| 5 |
DoorDash
DASH
|
+$251M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.88% |
| 2 | Financials | 15.2% |
| 3 | Healthcare | 13.93% |
| 4 | Consumer Discretionary | 13.71% |
| 5 | Industrials | 8.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2176
Crawford & Co Class A
CRD.A
$536M
| $133K | ﹤0.01% |
+12,600
| New | +$134K |
|
2177
Adaptive Biotechnologies
ADPT
$3.56B
| $133K | ﹤0.01% |
11,400
| – | – |
|
|
PBPB
2178
DELISTED
Potbelly
PBPB
| $132K | ﹤0.01% |
+10,800
| New | +$106K |
|
2179
Clean Energy Fuels
CLNE
$447M
| $129K | ﹤0.01% |
66,100
-1,400
| -2% | -$2.38K |
|
2180
Aemetis
AMTX
$119M
| $127K | ﹤0.01% |
+51,400
| New | +$86.9K |
|
|
SLSR
2181
Solaris Resources
SLSR
$1.28B
| $126K | ﹤0.01% |
27,500
-29,100
| -51% | -$118K |
|
|
SHYF
2182
DELISTED
The Shyft Group
SHYF
| $125K | ﹤0.01% |
10,000
-73,275
| -88% | -$718K |
|
2183
eGain
EGAN
$176M
| $125K | ﹤0.01% |
20,000
-21,100
| -51% | -$113K |
|
|
CMBM
2184
DELISTED
Cambium Networks
CMBM
| $123K | ﹤0.01% |
303,212
+222,912
| +278% | +$86.7K |
|
|
GAU
2185
Galiano Gold
GAU
$486M
| $123K | ﹤0.01% |
96,500
-69,900
| -42% | -$95K |
|
2186
Perion Network
PERI
$367M
| $122K | ﹤0.01% |
12,000
-5,400
| -31% | -$51.6K |
|
2187
Cato Corp
CATO
$65.9M
| $121K | ﹤0.01% |
42,900
-12,900
| -23% | -$34.3K |
|
|
CRON
2188
Cronos Group
CRON
$1.05B
| $120K | ﹤0.01% |
62,700
-66,757
| -52% | -$127K |
|
2189
Xperi
XPER
$365M
| $119K | ﹤0.01% |
15,100
| – | – |
|
2190
Precigen
PGEN
$1.93B
| $119K | ﹤0.01% |
83,600
+1,900
| +2% | +$2.7K |
|
2191
Aldeyra Therapeutics
ALDX
$91.7M
| $118K | ﹤0.01% |
30,800
-2,300
| -7% | -$5.95K |
|
|
CLYM
2192
Climb Bio
CLYM
$735M
| $118K | ﹤0.01% |
94,900
-19,100
| -17% | -$23.8K |
|
2193
Lifestance Health
LFST
$4.16B
| $115K | ﹤0.01% |
22,300
+3,300
| +17% | +$19.8K |
|
2194
Gevo
GEVO
$397M
| $115K | ﹤0.01% |
87,300
-2,800
| -3% | -$3.28K |
|
|
ETWO
2195
DELISTED
E2open Parent Holdings
ETWO
| $115K | ﹤0.01% |
35,600
-3,800
| -10% | -$10K |
|
|
TMQ
2196
Trilogy Metals
TMQ
$522M
| $115K | ﹤0.01% |
85,100
-62,500
| -42% | -$88K |
|
2197
Corbus Pharmaceuticals
CRBP
$170M
| $113K | ﹤0.01% |
16,340
-19,800
| -55% | -$144K |
|
2198
Codexis
CDXS
$135M
| $112K | ﹤0.01% |
46,000
-53,500
| -54% | -$125K |
|
|
TEAD
2199
Teads Holding Co
TEAD
$75.2M
| $112K | ﹤0.01% |
45,100
+28,300
| +168% | +$85.6K |
|
2200
RE/MAX Holdings
RMAX
$200M
| $108K | ﹤0.01% |
13,200
-1,700
| -11% | -$13.2K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q2 2025 Portfolio in Review
As of Q2 2025, Two Sigma Advisers held 2,611 positions worth $48.8B, up 9.9% from $44.4B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Two Sigma Advisers's Q2 2025 filing shows 251 new, 862 increased, 1,166 reduced and 311 closed positions. Its largest new stake was UnitedHealth: 759,500 shares worth $237M. The largest sale was Broadcom, an estimated $768M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.
- Two Sigma Advisers's largest Q2 2025 buy was UnitedHealth: 759,500 shares worth $237M.
- Two Sigma Advisers added most to T-Mobile US in Q2 2025, an estimated $479M increase.
- Two Sigma Advisers's biggest Q2 2025 reduction was Broadcom, cutting an estimated $768M.
- Two Sigma Advisers fully exited Advanced Micro Devices in Q2 2025, selling an estimated $155M.
- Two Sigma Advisers's ten largest holdings make up 19% of its $48.8B portfolio in Q2 2025.
- Two Sigma Advisers opened 251 new positions and closed 311 in Q2 2025.
- Two Sigma Advisers's portfolio value rose 9.9% quarter-over-quarter to $48.8B.
Based on Two Sigma Advisers's 13F filing for Q2 2025, filed 14 Aug 2025.